These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8578756)

  • 1. [Incidence of ovarian hyperstimulation syndrome in in-vitro-fertilization treatment over a period of 11 years].
    Niederberger V; Rottensteiner-Grohsmann C; Turnheim K; Obruca A; Brunner M; Feichtinger W
    Wien Med Wochenschr; 1995; 145(23):642-5. PubMed ID: 8578756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.
    Huddleston HG; Racowsky C; Jackson KV; Fox JH; Ginsburg ES
    Fertil Steril; 2008 Oct; 90(4):1259-62. PubMed ID: 18163999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
    Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
    Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH agonist administration after embryo transfer, in long protocol stimulated cycles, prevents ovarian hyperstimulation syndrome. A report of five cases.
    Nikolettos N; Asimakopoulos B; Simopoulou M; al-Hasani S
    In Vivo; 2003; 17(6):655-8. PubMed ID: 14758735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.
    Selman H; Brusco GF; Fiorini F; Barnocchi N; Mariani M; El-Danasouri I
    Fertil Steril; 2009 Apr; 91(4 Suppl):1611-3. PubMed ID: 19200960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection].
    Lin J; Ye B; Zhao J; Zhou Y; Huang X; Zheng J
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):601-3. PubMed ID: 12487934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates.
    Strawn EY; Roesler M; Rinke M; Aiman EJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1623-8. PubMed ID: 10871488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
    Delvigne A; Vandromme J; Demeestere I; Leroy F
    Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of severe ovarian hyperstimulation syndrome after inadvertent stimulation with a gonadotropin-releasing hormone agonist and human menopausal gonadotropin in a pre-existing early pregnancy.
    Zech NH; Netzbandt P; Zech H
    Fertil Steril; 2005 Dec; 84(6):1745. PubMed ID: 16359980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
    Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
    Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.